glp 1 anorexia nervosa Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge eating disorder? And how can clinicians protect patients from risk? An analysis on the role

Andrade AJ, et al

Antioxidants & redox signaling

This shift underscores the FDAs preference for patients to use approved, regulated medications when they are available

The drug has a short half-life and needs to be administered by subcutaneous injection three times a day

Open Med 15(1):689696 Kojima M, Takahashi H, Kuwashiro T, Tanaka K, Mori H, Ozaki I, Kitajima Y, Matsuda Y, Ashida K, Eguchi Y, Anzai K (2020) Glucagon-like peptide-1 receptor agonist prevented the progression of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis

United Kingdom Last summer, health officials in the United Kingdom took a similar approach to Sweden's, urging providers to stop prescribing appetite-suppressing medications for weight loss due to shortages for patients with diabetes